Skip to main content

Table 1 Variables collected at assessment time points

From: Estudio Parto: postpartum diabetes prevention program for hispanic women with abnormal glucose tolerance in pregnancy: a randomised controlled trial – study protocol

 

Pregnancy

Postpartum

 

3rd trimester

6 wks

6 mos

12 mos

Aim #1: Postpartum weight loss

X

X

X

X

Aim #2: Postpartum biomarkers of insulin resistance

    

Glucose

X

X

X

X

Insulin

X

X

X

X

HbA1c

X

X

X

X

Adiponectin

X

X

X

X

Leptin

X

X

X

X

TNF-α

X

X

X

X

HOMA

X

X

X

X

Area-Under-The-Glucose Curve (AUC)

X

X

X

X

Aim #3: Other postpartum biomarkers of cardiovascular risk

    

Total cholesterol

X

X

X

X

Triglycerides

X

X

X

X

HDL-Cholesterol

X

X

X

X

LDL-Cholesterol

X

X

X

X

Systolic blood pressure

X

X

X

X

Diastolic blood pressure

X

X

X

X

CRP

X

X

X

X

Fetuin-A

X

X

X

X

Albumin-to-creatinine ratio (ACR),

X

   

Aim #4: Behavioral outcomes

    

Physical activity (actigraph, PPAQ)

X

X

X

X

Dietary intake (24-hr recalls)

X

X

X

X

Censoring variables

    

Postpartumpregnancy test (urine)

 

X

X

X

75 g OGTT (postpartum)

 

X

X

X

Eligibility variables

    

100 g OGTT (prenatal)

X

   

Covariates

    

Clinical characteristics of the current pregnancy

X

   

Gestational weight gain

X

   

Medical history

X

   

Sociodemographic factors

X

   

Smoking (Cotinine) and substance use

X

X

X

X

Postpartum factors (e.g., sleep, depression, breastfeeding)

 

X

X

X